Medical Care
Global Dementia Digital Therapeutics Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 04, 25
- ID: 566636
- Pages: 120
- Figures: 116
- Views: 7
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Dementia Digital Therapeutics market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Brain+
Theoria technologies
Mynd Immersive
Cognito Therapeutics
LUCID, Inc.
Mindpax
Together Senior Health
Neuroglee
Segment by Type
App-based Interventions
Internet-based Interventions
Wearable Technologies
VR and AR Technologies
Segment by Application
Cognitive Training
Behavior Management
Assistance with Daily Living Activities
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Dementia Digital Therapeutics study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Dementia Digital Therapeutics market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Brain+
Theoria technologies
Mynd Immersive
Cognito Therapeutics
LUCID, Inc.
Mindpax
Together Senior Health
Neuroglee
Segment by Type
App-based Interventions
Internet-based Interventions
Wearable Technologies
VR and AR Technologies
Segment by Application
Cognitive Training
Behavior Management
Assistance with Daily Living Activities
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Dementia Digital Therapeutics study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Dementia Digital Therapeutics: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Dementia Digital Therapeutics Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 App-based Interventions
1.2.3 Internet-based Interventions
1.2.4 Wearable Technologies
1.2.5 VR and AR Technologies
1.3 Market Segmentation by Application
1.3.1 Global Dementia Digital Therapeutics Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cognitive Training
1.3.3 Behavior Management
1.3.4 Assistance with Daily Living Activities
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dementia Digital Therapeutics Revenue Estimates and Forecasts 2020-2031
2.2 Global Dementia Digital Therapeutics Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Dementia Digital Therapeutics Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Dementia Digital Therapeutics Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 App-based Interventions Market Size by Players
3.3.2 Internet-based Interventions Market Size by Players
3.3.3 Wearable Technologies Market Size by Players
3.3.4 VR and AR Technologies Market Size by Players
3.4 Global Dementia Digital Therapeutics Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Dementia Digital Therapeutics Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Dementia Digital Therapeutics Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Dementia Digital Therapeutics Market Size by Type (2020-2031)
6.4 North America Dementia Digital Therapeutics Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Dementia Digital Therapeutics Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Dementia Digital Therapeutics Market Size by Type (2020-2031)
7.4 Europe Dementia Digital Therapeutics Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Dementia Digital Therapeutics Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Dementia Digital Therapeutics Market Size by Type (2020-2031)
8.4 Asia-Pacific Dementia Digital Therapeutics Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Dementia Digital Therapeutics Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Dementia Digital Therapeutics Market Size by Type (2020-2031)
9.4 Central and South America Dementia Digital Therapeutics Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Dementia Digital Therapeutics Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Dementia Digital Therapeutics Market Size by Type (2020-2031)
10.4 Middle East and Africa Dementia Digital Therapeutics Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Dementia Digital Therapeutics Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Brain+
11.1.1 Brain+ Corporation Information
11.1.2 Brain+ Business Overview
11.1.3 Brain+ Dementia Digital Therapeutics Product Features and Attributes
11.1.4 Brain+ Dementia Digital Therapeutics Revenue and Gross Margin (2020-2025)
11.1.5 Brain+ Dementia Digital Therapeutics Revenue by Product in 2024
11.1.6 Brain+ Dementia Digital Therapeutics Revenue by Application in 2024
11.1.7 Brain+ Dementia Digital Therapeutics Revenue by Geographic Area in 2024
11.1.8 Brain+ Dementia Digital Therapeutics SWOT Analysis
11.1.9 Brain+ Recent Developments
11.2 Theoria technologies
11.2.1 Theoria technologies Corporation Information
11.2.2 Theoria technologies Business Overview
11.2.3 Theoria technologies Dementia Digital Therapeutics Product Features and Attributes
11.2.4 Theoria technologies Dementia Digital Therapeutics Revenue and Gross Margin (2020-2025)
11.2.5 Theoria technologies Dementia Digital Therapeutics Revenue by Product in 2024
11.2.6 Theoria technologies Dementia Digital Therapeutics Revenue by Application in 2024
11.2.7 Theoria technologies Dementia Digital Therapeutics Revenue by Geographic Area in 2024
11.2.8 Theoria technologies Dementia Digital Therapeutics SWOT Analysis
11.2.9 Theoria technologies Recent Developments
11.3 Mynd Immersive
11.3.1 Mynd Immersive Corporation Information
11.3.2 Mynd Immersive Business Overview
11.3.3 Mynd Immersive Dementia Digital Therapeutics Product Features and Attributes
11.3.4 Mynd Immersive Dementia Digital Therapeutics Revenue and Gross Margin (2020-2025)
11.3.5 Mynd Immersive Dementia Digital Therapeutics Revenue by Product in 2024
11.3.6 Mynd Immersive Dementia Digital Therapeutics Revenue by Application in 2024
11.3.7 Mynd Immersive Dementia Digital Therapeutics Revenue by Geographic Area in 2024
11.3.8 Mynd Immersive Dementia Digital Therapeutics SWOT Analysis
11.3.9 Mynd Immersive Recent Developments
11.4 Cognito Therapeutics
11.4.1 Cognito Therapeutics Corporation Information
11.4.2 Cognito Therapeutics Business Overview
11.4.3 Cognito Therapeutics Dementia Digital Therapeutics Product Features and Attributes
11.4.4 Cognito Therapeutics Dementia Digital Therapeutics Revenue and Gross Margin (2020-2025)
11.4.5 Cognito Therapeutics Dementia Digital Therapeutics Revenue by Product in 2024
11.4.6 Cognito Therapeutics Dementia Digital Therapeutics Revenue by Application in 2024
11.4.7 Cognito Therapeutics Dementia Digital Therapeutics Revenue by Geographic Area in 2024
11.4.8 Cognito Therapeutics Dementia Digital Therapeutics SWOT Analysis
11.4.9 Cognito Therapeutics Recent Developments
11.5 LUCID, Inc.
11.5.1 LUCID, Inc. Corporation Information
11.5.2 LUCID, Inc. Business Overview
11.5.3 LUCID, Inc. Dementia Digital Therapeutics Product Features and Attributes
11.5.4 LUCID, Inc. Dementia Digital Therapeutics Revenue and Gross Margin (2020-2025)
11.5.5 LUCID, Inc. Dementia Digital Therapeutics Revenue by Product in 2024
11.5.6 LUCID, Inc. Dementia Digital Therapeutics Revenue by Application in 2024
11.5.7 LUCID, Inc. Dementia Digital Therapeutics Revenue by Geographic Area in 2024
11.5.8 LUCID, Inc. Dementia Digital Therapeutics SWOT Analysis
11.5.9 LUCID, Inc. Recent Developments
11.6 Mindpax
11.6.1 Mindpax Corporation Information
11.6.2 Mindpax Business Overview
11.6.3 Mindpax Dementia Digital Therapeutics Product Features and Attributes
11.6.4 Mindpax Dementia Digital Therapeutics Revenue and Gross Margin (2020-2025)
11.6.5 Mindpax Recent Developments
11.7 Together Senior Health
11.7.1 Together Senior Health Corporation Information
11.7.2 Together Senior Health Business Overview
11.7.3 Together Senior Health Dementia Digital Therapeutics Product Features and Attributes
11.7.4 Together Senior Health Dementia Digital Therapeutics Revenue and Gross Margin (2020-2025)
11.7.5 Together Senior Health Recent Developments
11.8 Neuroglee
11.8.1 Neuroglee Corporation Information
11.8.2 Neuroglee Business Overview
11.8.3 Neuroglee Dementia Digital Therapeutics Product Features and Attributes
11.8.4 Neuroglee Dementia Digital Therapeutics Revenue and Gross Margin (2020-2025)
11.8.5 Neuroglee Recent Developments
12 Dementia Digital TherapeuticsIndustry Chain Analysis
12.1 Dementia Digital Therapeutics Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Dementia Digital Therapeutics Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Dementia Digital Therapeutics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Dementia Digital Therapeutics: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Dementia Digital Therapeutics Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 App-based Interventions
1.2.3 Internet-based Interventions
1.2.4 Wearable Technologies
1.2.5 VR and AR Technologies
1.3 Market Segmentation by Application
1.3.1 Global Dementia Digital Therapeutics Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cognitive Training
1.3.3 Behavior Management
1.3.4 Assistance with Daily Living Activities
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dementia Digital Therapeutics Revenue Estimates and Forecasts 2020-2031
2.2 Global Dementia Digital Therapeutics Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Dementia Digital Therapeutics Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Dementia Digital Therapeutics Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 App-based Interventions Market Size by Players
3.3.2 Internet-based Interventions Market Size by Players
3.3.3 Wearable Technologies Market Size by Players
3.3.4 VR and AR Technologies Market Size by Players
3.4 Global Dementia Digital Therapeutics Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Dementia Digital Therapeutics Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Dementia Digital Therapeutics Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Dementia Digital Therapeutics Market Size by Type (2020-2031)
6.4 North America Dementia Digital Therapeutics Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Dementia Digital Therapeutics Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Dementia Digital Therapeutics Market Size by Type (2020-2031)
7.4 Europe Dementia Digital Therapeutics Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Dementia Digital Therapeutics Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Dementia Digital Therapeutics Market Size by Type (2020-2031)
8.4 Asia-Pacific Dementia Digital Therapeutics Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Dementia Digital Therapeutics Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Dementia Digital Therapeutics Market Size by Type (2020-2031)
9.4 Central and South America Dementia Digital Therapeutics Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Dementia Digital Therapeutics Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Dementia Digital Therapeutics Market Size by Type (2020-2031)
10.4 Middle East and Africa Dementia Digital Therapeutics Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Dementia Digital Therapeutics Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Brain+
11.1.1 Brain+ Corporation Information
11.1.2 Brain+ Business Overview
11.1.3 Brain+ Dementia Digital Therapeutics Product Features and Attributes
11.1.4 Brain+ Dementia Digital Therapeutics Revenue and Gross Margin (2020-2025)
11.1.5 Brain+ Dementia Digital Therapeutics Revenue by Product in 2024
11.1.6 Brain+ Dementia Digital Therapeutics Revenue by Application in 2024
11.1.7 Brain+ Dementia Digital Therapeutics Revenue by Geographic Area in 2024
11.1.8 Brain+ Dementia Digital Therapeutics SWOT Analysis
11.1.9 Brain+ Recent Developments
11.2 Theoria technologies
11.2.1 Theoria technologies Corporation Information
11.2.2 Theoria technologies Business Overview
11.2.3 Theoria technologies Dementia Digital Therapeutics Product Features and Attributes
11.2.4 Theoria technologies Dementia Digital Therapeutics Revenue and Gross Margin (2020-2025)
11.2.5 Theoria technologies Dementia Digital Therapeutics Revenue by Product in 2024
11.2.6 Theoria technologies Dementia Digital Therapeutics Revenue by Application in 2024
11.2.7 Theoria technologies Dementia Digital Therapeutics Revenue by Geographic Area in 2024
11.2.8 Theoria technologies Dementia Digital Therapeutics SWOT Analysis
11.2.9 Theoria technologies Recent Developments
11.3 Mynd Immersive
11.3.1 Mynd Immersive Corporation Information
11.3.2 Mynd Immersive Business Overview
11.3.3 Mynd Immersive Dementia Digital Therapeutics Product Features and Attributes
11.3.4 Mynd Immersive Dementia Digital Therapeutics Revenue and Gross Margin (2020-2025)
11.3.5 Mynd Immersive Dementia Digital Therapeutics Revenue by Product in 2024
11.3.6 Mynd Immersive Dementia Digital Therapeutics Revenue by Application in 2024
11.3.7 Mynd Immersive Dementia Digital Therapeutics Revenue by Geographic Area in 2024
11.3.8 Mynd Immersive Dementia Digital Therapeutics SWOT Analysis
11.3.9 Mynd Immersive Recent Developments
11.4 Cognito Therapeutics
11.4.1 Cognito Therapeutics Corporation Information
11.4.2 Cognito Therapeutics Business Overview
11.4.3 Cognito Therapeutics Dementia Digital Therapeutics Product Features and Attributes
11.4.4 Cognito Therapeutics Dementia Digital Therapeutics Revenue and Gross Margin (2020-2025)
11.4.5 Cognito Therapeutics Dementia Digital Therapeutics Revenue by Product in 2024
11.4.6 Cognito Therapeutics Dementia Digital Therapeutics Revenue by Application in 2024
11.4.7 Cognito Therapeutics Dementia Digital Therapeutics Revenue by Geographic Area in 2024
11.4.8 Cognito Therapeutics Dementia Digital Therapeutics SWOT Analysis
11.4.9 Cognito Therapeutics Recent Developments
11.5 LUCID, Inc.
11.5.1 LUCID, Inc. Corporation Information
11.5.2 LUCID, Inc. Business Overview
11.5.3 LUCID, Inc. Dementia Digital Therapeutics Product Features and Attributes
11.5.4 LUCID, Inc. Dementia Digital Therapeutics Revenue and Gross Margin (2020-2025)
11.5.5 LUCID, Inc. Dementia Digital Therapeutics Revenue by Product in 2024
11.5.6 LUCID, Inc. Dementia Digital Therapeutics Revenue by Application in 2024
11.5.7 LUCID, Inc. Dementia Digital Therapeutics Revenue by Geographic Area in 2024
11.5.8 LUCID, Inc. Dementia Digital Therapeutics SWOT Analysis
11.5.9 LUCID, Inc. Recent Developments
11.6 Mindpax
11.6.1 Mindpax Corporation Information
11.6.2 Mindpax Business Overview
11.6.3 Mindpax Dementia Digital Therapeutics Product Features and Attributes
11.6.4 Mindpax Dementia Digital Therapeutics Revenue and Gross Margin (2020-2025)
11.6.5 Mindpax Recent Developments
11.7 Together Senior Health
11.7.1 Together Senior Health Corporation Information
11.7.2 Together Senior Health Business Overview
11.7.3 Together Senior Health Dementia Digital Therapeutics Product Features and Attributes
11.7.4 Together Senior Health Dementia Digital Therapeutics Revenue and Gross Margin (2020-2025)
11.7.5 Together Senior Health Recent Developments
11.8 Neuroglee
11.8.1 Neuroglee Corporation Information
11.8.2 Neuroglee Business Overview
11.8.3 Neuroglee Dementia Digital Therapeutics Product Features and Attributes
11.8.4 Neuroglee Dementia Digital Therapeutics Revenue and Gross Margin (2020-2025)
11.8.5 Neuroglee Recent Developments
12 Dementia Digital TherapeuticsIndustry Chain Analysis
12.1 Dementia Digital Therapeutics Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Dementia Digital Therapeutics Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Dementia Digital Therapeutics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Dementia Digital Therapeutics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Dementia Digital Therapeutics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Dementia Digital Therapeutics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Dementia Digital Therapeutics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Dementia Digital Therapeutics Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Dementia Digital Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Dementia Digital Therapeutics Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Dementia Digital Therapeutics by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia Digital Therapeutics as of 2024)
Table 11. Global Dementia Digital Therapeutics Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Dementia Digital Therapeutics Companies Headquarters
Table 13. Global Dementia Digital Therapeutics Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Dementia Digital Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Dementia Digital Therapeutics Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Dementia Digital Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Dementia Digital Therapeutics Revenue by Application (2026-2031) & (US$ Million)
Table 21. Dementia Digital Therapeutics High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Dementia Digital Therapeutics Growth Accelerators and Market Barriers
Table 25. North America Dementia Digital Therapeutics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Dementia Digital Therapeutics Growth Accelerators and Market Barriers
Table 27. Europe Dementia Digital Therapeutics Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Dementia Digital Therapeutics Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Dementia Digital Therapeutics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Dementia Digital Therapeutics Investment Opportunities and Key Challenges
Table 31. Central and South America Dementia Digital Therapeutics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Dementia Digital Therapeutics Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Dementia Digital Therapeutics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Brain+ Corporation Information
Table 35. Brain+ Description and Major Businesses
Table 36. Brain+ Product Features and Attributes
Table 37. Brain+ Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Brain+ Revenue Proportion by Product in 2024
Table 39. Brain+ Revenue Proportion by Application in 2024
Table 40. Brain+ Revenue Proportion by Geographic Area in 2024
Table 41. Brain+ Dementia Digital Therapeutics SWOT Analysis
Table 42. Brain+ Recent Developments
Table 43. Theoria technologies Corporation Information
Table 44. Theoria technologies Description and Major Businesses
Table 45. Theoria technologies Product Features and Attributes
Table 46. Theoria technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Theoria technologies Revenue Proportion by Product in 2024
Table 48. Theoria technologies Revenue Proportion by Application in 2024
Table 49. Theoria technologies Revenue Proportion by Geographic Area in 2024
Table 50. Theoria technologies Dementia Digital Therapeutics SWOT Analysis
Table 51. Theoria technologies Recent Developments
Table 52. Mynd Immersive Corporation Information
Table 53. Mynd Immersive Description and Major Businesses
Table 54. Mynd Immersive Product Features and Attributes
Table 55. Mynd Immersive Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Mynd Immersive Revenue Proportion by Product in 2024
Table 57. Mynd Immersive Revenue Proportion by Application in 2024
Table 58. Mynd Immersive Revenue Proportion by Geographic Area in 2024
Table 59. Mynd Immersive Dementia Digital Therapeutics SWOT Analysis
Table 60. Mynd Immersive Recent Developments
Table 61. Cognito Therapeutics Corporation Information
Table 62. Cognito Therapeutics Description and Major Businesses
Table 63. Cognito Therapeutics Product Features and Attributes
Table 64. Cognito Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Cognito Therapeutics Revenue Proportion by Product in 2024
Table 66. Cognito Therapeutics Revenue Proportion by Application in 2024
Table 67. Cognito Therapeutics Revenue Proportion by Geographic Area in 2024
Table 68. Cognito Therapeutics Dementia Digital Therapeutics SWOT Analysis
Table 69. Cognito Therapeutics Recent Developments
Table 70. LUCID, Inc. Corporation Information
Table 71. LUCID, Inc. Description and Major Businesses
Table 72. LUCID, Inc. Product Features and Attributes
Table 73. LUCID, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. LUCID, Inc. Revenue Proportion by Product in 2024
Table 75. LUCID, Inc. Revenue Proportion by Application in 2024
Table 76. LUCID, Inc. Revenue Proportion by Geographic Area in 2024
Table 77. LUCID, Inc. Dementia Digital Therapeutics SWOT Analysis
Table 78. LUCID, Inc. Recent Developments
Table 79. Mindpax Corporation Information
Table 80. Mindpax Description and Major Businesses
Table 81. Mindpax Product Features and Attributes
Table 82. Mindpax Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Mindpax Recent Developments
Table 84. Together Senior Health Corporation Information
Table 85. Together Senior Health Description and Major Businesses
Table 86. Together Senior Health Product Features and Attributes
Table 87. Together Senior Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Together Senior Health Recent Developments
Table 89. Neuroglee Corporation Information
Table 90. Neuroglee Description and Major Businesses
Table 91. Neuroglee Product Features and Attributes
Table 92. Neuroglee Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Neuroglee Recent Developments
Table 94. Raw Materials Key Suppliers
Table 95. Distributors List
Table 96. Market Trends and Market Evolution
Table 97. Market Drivers and Opportunities
Table 98. Market Challenges, Risks, and Restraints
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Dementia Digital Therapeutics Product Picture
Figure 2. Global Dementia Digital Therapeutics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. App-based Interventions Product Picture
Figure 4. Internet-based Interventions Product Picture
Figure 5. Wearable Technologies Product Picture
Figure 6. VR and AR Technologies Product Picture
Figure 7. Global Dementia Digital Therapeutics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Cognitive Training
Figure 9. Behavior Management
Figure 10. Assistance with Daily Living Activities
Figure 11. Others
Figure 12. Dementia Digital Therapeutics Report Years Considered
Figure 13. Global Dementia Digital Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 15. Global Dementia Digital Therapeutics Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Dementia Digital Therapeutics Revenue Market Share by Region (2020-2031)
Figure 17. Global Dementia Digital Therapeutics Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. App-based Interventions Revenue Market Share by Player in 2024
Figure 20. Internet-based Interventions Revenue Market Share by Player in 2024
Figure 21. Wearable Technologies Revenue Market Share by Player in 2024
Figure 22. VR and AR Technologies Revenue Market Share by Player in 2024
Figure 23. Global Dementia Digital Therapeutics Revenue Market Share by Type (2020-2031)
Figure 24. Global Dementia Digital Therapeutics Revenue Market Share by Application (2020-2031)
Figure 25. North America Dementia Digital Therapeutics Revenue YoY (2020-2031) & (US$ Million)
Figure 26. North America Top 5 Players Dementia Digital Therapeutics Revenue (US$ Million) in 2024
Figure 27. North America Dementia Digital Therapeutics Revenue (US$ Million) by Type (2020 - 2031)
Figure 28. North America Dementia Digital Therapeutics Revenue (US$ Million) by Application (2020-2031)
Figure 29. US Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 30. Canada Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 31. Mexico Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 32. Europe Dementia Digital Therapeutics Revenue YoY (2020-2031) & (US$ Million)
Figure 33. Europe Top 5 Players Dementia Digital Therapeutics Revenue (US$ Million) in 2024
Figure 34. Europe Dementia Digital Therapeutics Revenue (US$ Million) by Type (2020-2031)
Figure 35. Europe Dementia Digital Therapeutics Revenue (US$ Million) by Application (2020-2031)
Figure 36. Germany Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 37. France Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 38. U.K. Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 39. Italy Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 40. Russia Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Dementia Digital Therapeutics Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Top 8 Players Dementia Digital Therapeutics Revenue (US$ Million) in 2024
Figure 43. Asia-Pacific Dementia Digital Therapeutics Revenue (US$ Million) by Type (2020-2031)
Figure 44. Asia-Pacific Dementia Digital Therapeutics Revenue (US$ Million) by Application (2020-2031)
Figure 45. Indonesia Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 46. Japan Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 47. South Korea Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 48. Australia Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 49. India Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 50. Indonesia Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 51. Vietnam Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 52. Malaysia Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 53. Philippines Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 54. Singapore Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 55. Central and South America Dementia Digital Therapeutics Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Central and South America Top 5 Players Dementia Digital Therapeutics Revenue (US$ Million) in 2024
Figure 57. Central and South America Dementia Digital Therapeutics Revenue (US$ Million) by Type (2020-2031)
Figure 58. Central and South America Dementia Digital Therapeutics Revenue (US$ Million) by Application (2020-2031)
Figure 59. Brazil Dementia Digital Therapeutics Revenue (2020-2025) & (US$ Million)
Figure 60. Argentina Dementia Digital Therapeutics Revenue (2020-2025) & (US$ Million)
Figure 61. Middle East and Africa Dementia Digital Therapeutics Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Middle East and Africa Top 5 Players Dementia Digital Therapeutics Revenue (US$ Million) in 2024
Figure 63. South America Dementia Digital Therapeutics Revenue (US$ Million) by Type (2020-2031)
Figure 64. Middle East and Africa Dementia Digital Therapeutics Revenue (US$ Million) by Application (2020-2031)
Figure 65. GCC Countries Dementia Digital Therapeutics Revenue (2020-2025) & (US$ Million)
Figure 66. Israel Dementia Digital Therapeutics Revenue (2020-2025) & (US$ Million)
Figure 67. Egypt Dementia Digital Therapeutics Revenue (2020-2025) & (US$ Million)
Figure 68. South Africa Dementia Digital Therapeutics Revenue (2020-2025) & (US$ Million)
Figure 69. Dementia Digital Therapeutics Industry Chain Mapping
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Table 1. Global Dementia Digital Therapeutics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Dementia Digital Therapeutics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Dementia Digital Therapeutics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Dementia Digital Therapeutics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Dementia Digital Therapeutics Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Dementia Digital Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Dementia Digital Therapeutics Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Dementia Digital Therapeutics by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia Digital Therapeutics as of 2024)
Table 11. Global Dementia Digital Therapeutics Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Dementia Digital Therapeutics Companies Headquarters
Table 13. Global Dementia Digital Therapeutics Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Dementia Digital Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Dementia Digital Therapeutics Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Dementia Digital Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Dementia Digital Therapeutics Revenue by Application (2026-2031) & (US$ Million)
Table 21. Dementia Digital Therapeutics High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Dementia Digital Therapeutics Growth Accelerators and Market Barriers
Table 25. North America Dementia Digital Therapeutics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Dementia Digital Therapeutics Growth Accelerators and Market Barriers
Table 27. Europe Dementia Digital Therapeutics Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Dementia Digital Therapeutics Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Dementia Digital Therapeutics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Dementia Digital Therapeutics Investment Opportunities and Key Challenges
Table 31. Central and South America Dementia Digital Therapeutics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Dementia Digital Therapeutics Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Dementia Digital Therapeutics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Brain+ Corporation Information
Table 35. Brain+ Description and Major Businesses
Table 36. Brain+ Product Features and Attributes
Table 37. Brain+ Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Brain+ Revenue Proportion by Product in 2024
Table 39. Brain+ Revenue Proportion by Application in 2024
Table 40. Brain+ Revenue Proportion by Geographic Area in 2024
Table 41. Brain+ Dementia Digital Therapeutics SWOT Analysis
Table 42. Brain+ Recent Developments
Table 43. Theoria technologies Corporation Information
Table 44. Theoria technologies Description and Major Businesses
Table 45. Theoria technologies Product Features and Attributes
Table 46. Theoria technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Theoria technologies Revenue Proportion by Product in 2024
Table 48. Theoria technologies Revenue Proportion by Application in 2024
Table 49. Theoria technologies Revenue Proportion by Geographic Area in 2024
Table 50. Theoria technologies Dementia Digital Therapeutics SWOT Analysis
Table 51. Theoria technologies Recent Developments
Table 52. Mynd Immersive Corporation Information
Table 53. Mynd Immersive Description and Major Businesses
Table 54. Mynd Immersive Product Features and Attributes
Table 55. Mynd Immersive Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Mynd Immersive Revenue Proportion by Product in 2024
Table 57. Mynd Immersive Revenue Proportion by Application in 2024
Table 58. Mynd Immersive Revenue Proportion by Geographic Area in 2024
Table 59. Mynd Immersive Dementia Digital Therapeutics SWOT Analysis
Table 60. Mynd Immersive Recent Developments
Table 61. Cognito Therapeutics Corporation Information
Table 62. Cognito Therapeutics Description and Major Businesses
Table 63. Cognito Therapeutics Product Features and Attributes
Table 64. Cognito Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Cognito Therapeutics Revenue Proportion by Product in 2024
Table 66. Cognito Therapeutics Revenue Proportion by Application in 2024
Table 67. Cognito Therapeutics Revenue Proportion by Geographic Area in 2024
Table 68. Cognito Therapeutics Dementia Digital Therapeutics SWOT Analysis
Table 69. Cognito Therapeutics Recent Developments
Table 70. LUCID, Inc. Corporation Information
Table 71. LUCID, Inc. Description and Major Businesses
Table 72. LUCID, Inc. Product Features and Attributes
Table 73. LUCID, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. LUCID, Inc. Revenue Proportion by Product in 2024
Table 75. LUCID, Inc. Revenue Proportion by Application in 2024
Table 76. LUCID, Inc. Revenue Proportion by Geographic Area in 2024
Table 77. LUCID, Inc. Dementia Digital Therapeutics SWOT Analysis
Table 78. LUCID, Inc. Recent Developments
Table 79. Mindpax Corporation Information
Table 80. Mindpax Description and Major Businesses
Table 81. Mindpax Product Features and Attributes
Table 82. Mindpax Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Mindpax Recent Developments
Table 84. Together Senior Health Corporation Information
Table 85. Together Senior Health Description and Major Businesses
Table 86. Together Senior Health Product Features and Attributes
Table 87. Together Senior Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Together Senior Health Recent Developments
Table 89. Neuroglee Corporation Information
Table 90. Neuroglee Description and Major Businesses
Table 91. Neuroglee Product Features and Attributes
Table 92. Neuroglee Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Neuroglee Recent Developments
Table 94. Raw Materials Key Suppliers
Table 95. Distributors List
Table 96. Market Trends and Market Evolution
Table 97. Market Drivers and Opportunities
Table 98. Market Challenges, Risks, and Restraints
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Dementia Digital Therapeutics Product Picture
Figure 2. Global Dementia Digital Therapeutics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. App-based Interventions Product Picture
Figure 4. Internet-based Interventions Product Picture
Figure 5. Wearable Technologies Product Picture
Figure 6. VR and AR Technologies Product Picture
Figure 7. Global Dementia Digital Therapeutics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Cognitive Training
Figure 9. Behavior Management
Figure 10. Assistance with Daily Living Activities
Figure 11. Others
Figure 12. Dementia Digital Therapeutics Report Years Considered
Figure 13. Global Dementia Digital Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 15. Global Dementia Digital Therapeutics Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Dementia Digital Therapeutics Revenue Market Share by Region (2020-2031)
Figure 17. Global Dementia Digital Therapeutics Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. App-based Interventions Revenue Market Share by Player in 2024
Figure 20. Internet-based Interventions Revenue Market Share by Player in 2024
Figure 21. Wearable Technologies Revenue Market Share by Player in 2024
Figure 22. VR and AR Technologies Revenue Market Share by Player in 2024
Figure 23. Global Dementia Digital Therapeutics Revenue Market Share by Type (2020-2031)
Figure 24. Global Dementia Digital Therapeutics Revenue Market Share by Application (2020-2031)
Figure 25. North America Dementia Digital Therapeutics Revenue YoY (2020-2031) & (US$ Million)
Figure 26. North America Top 5 Players Dementia Digital Therapeutics Revenue (US$ Million) in 2024
Figure 27. North America Dementia Digital Therapeutics Revenue (US$ Million) by Type (2020 - 2031)
Figure 28. North America Dementia Digital Therapeutics Revenue (US$ Million) by Application (2020-2031)
Figure 29. US Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 30. Canada Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 31. Mexico Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 32. Europe Dementia Digital Therapeutics Revenue YoY (2020-2031) & (US$ Million)
Figure 33. Europe Top 5 Players Dementia Digital Therapeutics Revenue (US$ Million) in 2024
Figure 34. Europe Dementia Digital Therapeutics Revenue (US$ Million) by Type (2020-2031)
Figure 35. Europe Dementia Digital Therapeutics Revenue (US$ Million) by Application (2020-2031)
Figure 36. Germany Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 37. France Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 38. U.K. Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 39. Italy Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 40. Russia Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Dementia Digital Therapeutics Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Top 8 Players Dementia Digital Therapeutics Revenue (US$ Million) in 2024
Figure 43. Asia-Pacific Dementia Digital Therapeutics Revenue (US$ Million) by Type (2020-2031)
Figure 44. Asia-Pacific Dementia Digital Therapeutics Revenue (US$ Million) by Application (2020-2031)
Figure 45. Indonesia Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 46. Japan Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 47. South Korea Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 48. Australia Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 49. India Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 50. Indonesia Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 51. Vietnam Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 52. Malaysia Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 53. Philippines Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 54. Singapore Dementia Digital Therapeutics Revenue (2020-2031) & (US$ Million)
Figure 55. Central and South America Dementia Digital Therapeutics Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Central and South America Top 5 Players Dementia Digital Therapeutics Revenue (US$ Million) in 2024
Figure 57. Central and South America Dementia Digital Therapeutics Revenue (US$ Million) by Type (2020-2031)
Figure 58. Central and South America Dementia Digital Therapeutics Revenue (US$ Million) by Application (2020-2031)
Figure 59. Brazil Dementia Digital Therapeutics Revenue (2020-2025) & (US$ Million)
Figure 60. Argentina Dementia Digital Therapeutics Revenue (2020-2025) & (US$ Million)
Figure 61. Middle East and Africa Dementia Digital Therapeutics Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Middle East and Africa Top 5 Players Dementia Digital Therapeutics Revenue (US$ Million) in 2024
Figure 63. South America Dementia Digital Therapeutics Revenue (US$ Million) by Type (2020-2031)
Figure 64. Middle East and Africa Dementia Digital Therapeutics Revenue (US$ Million) by Application (2020-2031)
Figure 65. GCC Countries Dementia Digital Therapeutics Revenue (2020-2025) & (US$ Million)
Figure 66. Israel Dementia Digital Therapeutics Revenue (2020-2025) & (US$ Million)
Figure 67. Egypt Dementia Digital Therapeutics Revenue (2020-2025) & (US$ Million)
Figure 68. South Africa Dementia Digital Therapeutics Revenue (2020-2025) & (US$ Million)
Figure 69. Dementia Digital Therapeutics Industry Chain Mapping
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232